MA20292A1 - Nouveaux derives de 2,2' -iminobisethanol, intermediaires pour leur preparation et procedes pour la preparation de ces derives et intermediaires. - Google Patents

Nouveaux derives de 2,2' -iminobisethanol, intermediaires pour leur preparation et procedes pour la preparation de ces derives et intermediaires.

Info

Publication number
MA20292A1
MA20292A1 MA20516A MA20516A MA20292A1 MA 20292 A1 MA20292 A1 MA 20292A1 MA 20516 A MA20516 A MA 20516A MA 20516 A MA20516 A MA 20516A MA 20292 A1 MA20292 A1 MA 20292A1
Authority
MA
Morocco
Prior art keywords
intermediates
preparation
derivatives
processes
new
Prior art date
Application number
MA20516A
Other languages
English (en)
Inventor
De Bruyn Marcel
Schroven Marc
Van Lommen Guy
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA20292A1 publication Critical patent/MA20292A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA20516A 1983-12-05 1984-12-04 Nouveaux derives de 2,2' -iminobisethanol, intermediaires pour leur preparation et procedes pour la preparation de ces derives et intermediaires. MA20292A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55808183A 1983-12-05 1983-12-05

Publications (1)

Publication Number Publication Date
MA20292A1 true MA20292A1 (fr) 1985-07-01

Family

ID=24228139

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20516A MA20292A1 (fr) 1983-12-05 1984-12-04 Nouveaux derives de 2,2' -iminobisethanol, intermediaires pour leur preparation et procedes pour la preparation de ces derives et intermediaires.

Country Status (32)

Country Link
EP (1) EP0145067B1 (fr)
JP (1) JPS60132977A (fr)
KR (1) KR870000923B1 (fr)
AR (1) AR241414A1 (fr)
AT (1) ATE40361T1 (fr)
AU (1) AU573658B2 (fr)
BG (1) BG43866A3 (fr)
CA (1) CA1337429C (fr)
CS (1) CS250242B2 (fr)
CY (1) CY1609A (fr)
DD (1) DD235453A5 (fr)
DE (1) DE3476388D1 (fr)
DK (2) DK165112C (fr)
DZ (1) DZ712A1 (fr)
ES (1) ES538256A0 (fr)
FI (1) FI82460C (fr)
GR (1) GR81098B (fr)
HK (1) HK52791A (fr)
HU (1) HU202219B (fr)
IE (1) IE57831B1 (fr)
IL (1) IL73706A (fr)
MA (1) MA20292A1 (fr)
NO (2) NO169839C (fr)
NZ (1) NZ210388A (fr)
PH (1) PH22432A (fr)
PL (1) PL146342B1 (fr)
PT (1) PT79609B (fr)
RO (1) RO91184B (fr)
SG (1) SG47091G (fr)
SU (1) SU1428199A3 (fr)
ZA (1) ZA849445B (fr)
ZW (1) ZW19784A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337432C (fr) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Methode de reduction de la tension arterielle
JPH02103116U (fr) * 1989-02-01 1990-08-16
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd ６―フルオロクロモン―２―カルボン酸及びその製造法
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
PT707007E (pt) * 1994-10-14 2002-06-28 Merck Patent Gmbh Derivados amino(tio)eter como agentes activos no snc
ID26524A (id) * 1997-12-19 2001-01-11 Bayer Ag Turunan-turunan kroman tersubstitusi karboksil bermanfaat sebagai agonis beta-3 adrenoreseptor
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
WO2002087508A2 (fr) 2001-05-02 2002-11-07 Nitromed, Inc. Nebivolol nitrose et nitrosylate et ses metabolites, compositions et techniques d'utilisation
JP2004538289A (ja) 2001-07-26 2004-12-24 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ２−［５−（４−フルオロフェニル）−３−ピリジルメチルアミノメチル］−クロマンおよびその生理学的に許容し得る塩の新規な使用
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003042160A1 (fr) 2001-11-13 2003-05-22 Theravance, Inc. Agonistes de recepteur d'aryl aniline beta-2 adrenergique
CN101006081B (zh) 2004-07-30 2011-02-09 托伦特药物有限公司 奈必洛尔及其药学可接受盐、制备方法以及奈必洛尔的药物组合物
DE602004026789D1 (de) * 2004-08-11 2010-06-02 Hetero Drugs Ltd Neues verfahren zur herstellung von nebivololzwischenprodukten
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
AP2764A (en) * 2005-01-31 2013-09-30 Mylan Lab Inc Hydroxylated nebivolol metabolites
EP1850842A1 (fr) * 2005-02-11 2007-11-07 Stada Arzneimittel Ag Preparations pharmaceutiques comprenant du nebivolol et un polymere hydrophile
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (fr) * 2005-12-28 2012-07-25 Acino Pharma AG Un procédé pour la préparation de nebivolol racémique
EP1973895A1 (fr) 2006-01-18 2008-10-01 Hetero Drugs Limited Procédé d'isolement des isomères recherchés d'intermédiaires du nébivolol
ITMI20061889A1 (it) 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
PL2228374T3 (pl) 2006-11-27 2013-11-29 Zach System Spa Mrówczan nebiwololu
EP2124931A4 (fr) 2007-01-22 2013-08-28 Mylan Pharmaceuticals Ulc Compositions pharmaceutiques comprenant du nébivolol ou un analogue du nébivolol
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1392067B1 (it) * 2008-10-31 2012-02-09 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
PT2907809T (pt) 2014-02-14 2019-01-16 Corden Pharma Int Gmbh Processo sem base para a preparação de intermediários de cetona utilizáveis para fabrico de nebivolol
EP2907810A1 (fr) 2014-02-14 2015-08-19 Corden Pharma International GmbH Nouveau procédé de production chlorhydrate de nébivolol à haute pureté
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
PL3299364T3 (pl) 2015-05-19 2022-02-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Sposób syntezy nebiwololu i jego związek pośredni
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054655A (fr) * 1964-01-24
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
PT79609A (en) 1985-01-01
ES8603870A1 (es) 1986-01-01
NO2004007I1 (no) 2004-12-20
SU1428199A3 (ru) 1988-09-30
GR81098B (en) 1984-12-17
HUT37418A (en) 1985-12-28
NO169839B (no) 1992-05-04
KR870000923B1 (ko) 1987-05-07
DK165321B (da) 1992-11-09
DD235453A5 (de) 1986-05-07
ZW19784A1 (en) 1986-07-02
DK165112C (da) 1993-03-01
PT79609B (en) 1986-12-12
KR850004485A (ko) 1985-07-15
EP0145067A3 (en) 1986-03-26
EP0145067A2 (fr) 1985-06-19
RO91184B (ro) 1987-07-31
ATE40361T1 (de) 1989-02-15
AU3632684A (en) 1985-06-13
NZ210388A (en) 1987-07-31
DK165112B (da) 1992-10-12
DK11892D0 (da) 1992-01-31
FI844777L (fi) 1985-06-06
DK577084D0 (da) 1984-12-04
PL146342B1 (en) 1989-01-31
PL250524A1 (en) 1986-02-25
FI844777A0 (fi) 1984-12-04
DE3476388D1 (en) 1989-03-02
HK52791A (en) 1991-07-19
JPH0250114B2 (fr) 1990-11-01
EP0145067B1 (fr) 1989-01-25
FI82460C (fi) 1991-03-11
AR241414A1 (es) 1992-07-31
PH22432A (en) 1988-09-12
IL73706A0 (en) 1985-03-31
SG47091G (en) 1991-07-26
CS250242B2 (en) 1987-04-16
CY1609A (en) 1992-04-03
FI82460B (fi) 1990-11-30
IL73706A (en) 1988-07-31
RO91184A (fr) 1987-07-30
CA1337429C (fr) 1995-10-24
DK165321C (da) 1993-03-29
IE57831B1 (en) 1993-04-21
DK577084A (da) 1985-06-06
AU573658B2 (en) 1988-06-16
IE843103L (en) 1985-06-05
NO169839C (no) 1992-08-12
HU202219B (en) 1991-02-28
DZ712A1 (fr) 2004-09-13
ES538256A0 (es) 1986-01-01
NO844845L (no) 1985-06-06
BG43866A3 (en) 1988-08-15
JPS60132977A (ja) 1985-07-16
NO2004007I2 (no) 2005-05-09
ZA849445B (en) 1986-07-30
DK11892A (da) 1992-01-31

Similar Documents

Publication Publication Date Title
MA20292A1 (fr) Nouveaux derives de 2,2' -iminobisethanol, intermediaires pour leur preparation et procedes pour la preparation de ces derives et intermediaires.
MA21645A1 (fr) Procede pour la preparation de nouveaux derives d'rtemisinine.
FR2498188B1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2509300B1 (fr) Derives d'azetidinone et procede pour leur preparation
ES510888A0 (es) "procedimiento para la produccion de derivados de 1-aril-2-azolileteno".
ES515730A0 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
MA21348A1 (fr) Procede pour la preparation de nouveaux derives aminoalcoxyphenyle.
MC1478A1 (fr) Nouveaux derives de l'imidazoquinazoline
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
ES499299A0 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
BR8201194A (pt) Preparacao de 2,3-dicloro-5-triclorometilpiridina
FR2571052B1 (fr) Derives de 1,3-oxazolidine-2-one et leur procede de preparation
ES516521A0 (es) "metodo de preparar intermedios de ftalimidinas, ftalacinonas y similares".
IT1147923B (it) Procedimento per la produzione di ditiazolil-2(2.2')-disolfuri
MA21167A1 (fr) Procede de preparation de nouveaux derives oxy-5 du tetrahydrofurane.
MC1410A1 (fr) Nouveaux derives de l'imidazoquinazoline
MA19177A1 (fr) Nouveaux derives de l'indene ,procedes pour leur preparation
NO830839L (no) Ny fremgangsmaate for fremstilling av 3,4-difenyl-5-metylpyrazolderivater.
FR2555578B1 (fr) Procede de preparation de derives d'azetidinone
MA21499A1 (fr) Procede de preparation de nouveaux derives de la i-arylsylfonyl 2-pyrrolidinone.
BE890853A (fr) Nouveaux derives de l'apramycine
RO85812A (fr) Procede pour la preparation des derives d'azolylpentene
NO158299C (no) Analogifremgangsmaate for fremstilling av 17, 18-dehydro-apovincaminol-l-3', 4', 5'-trimethoxy-benzoat.
RO79906A (fr) Procede pour la preparation des derives de 1,1'-diphenyle-2-ilalkylamine
MA21352A1 (fr) Procede de preparation de nouveaux derives de thieno-imidazole substitues.